NCT00273962 A Comparison of Combivent UDV (Ipratropium 500mcg and Salbutamol 2.5mg) and Salbutamol UDV Alone (2.5mg) Status COMPLETED Phase PHASE4
NCT00272753 Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations Status COMPLETED Phase PHASE4
NCT00272727 Improved Quality of the Treatment and Increased Compliance in Asthmatics Through the Dialog Tool Soren - Between Patient and Caregiver Status COMPLETED Phase NA
NCT00270348 Effects of Ciclesonide MDI 50mg/Day and 200mg/Day (Ex-Valve) Once-Daily on Growth in Children With Mild Persistent Asthma Status COMPLETED Phase PHASE3
NCT00269256 Stress, Environment, and Genetics in Urban Children With Asthma Status COMPLETED Phase N/A
NCT00267917 Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique. Status COMPLETED Phase PHASE4
NCT00264849 Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma Status COMPLETED Phase PHASE4
NCT00263159 Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study Status COMPLETED Phase NA
NCT00262340 The Use of Inflammatory Markers to Guide Therapy in Children With Severe Asthma Status COMPLETED Phase NA
NCT00259792 SYMPHONIE - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults Status COMPLETED Phase PHASE3